首页> 外文期刊>Protein Engineering, Design and Selection >Engineering of stable bispecific antibodies targeting IL-17A and IL-23

【24h】

Engineering of stable bispecific antibodies targeting IL-17A and IL-23

机译：工程针对IL-17A和IL-23的稳定双特异性抗体

获取原文

获取原文并翻译 | 示例

开具论文收录证明 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Protein Engineering, Design and Selection》 |2010年第3期|p.115-127|共13页
作者
Mark Snavely;
展开▼
作者单位

ZymoGenetics, Inc., @%@To whom correspondence should be addressed. E-mail:;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Engineering of stable bispecific antibodies targeting IL-17A and IL-23. [J] . Mabry R, Lewis KE, Moore M, Protein engineering design & selection: PEDS . 2010,第3a4期

机译：工程针对IL-17A和IL-23的稳定双特异性抗体。
2. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment. [J] . Cornelia Tillack, Laura Maximiliane Ehmann, Matthias Friedrich, Gut: Journal of the British Society of Gastroenterology . 2014,第4期

机译：抗TNF抗体诱导的炎性肠病患者牛皮癣样皮肤病变的特征在于表达干扰素的Th1细胞和表达IL-17A / IL-22的Th17细胞，并对抗IL-12 / IL-23抗体产生反应治疗。
3. Engineering a bispecific antibody with a common light chain: Identification and optimization of an anti-CD3 epsilon and anti-GPC3 bispecific antibody, ERY974 [J] . Shiraiwa Hirotake, Narita Atsushi, Kamata-Sakurai Mika, Methods: A Companion to Methods in Enzymology . 2019,第期

机译：用常见轻链的双特异性抗体：抗CD3ε和抗GPC3双特异性抗体的鉴定和优化，ERY974
4. The Benefits of Bispecific mAb-square Antibodies Targeting EGFR and HGF [C] . Melanie Medcalf, Kin-Mei Leung, Samine Isaac, Protein Engineering Summit. . 2018

机译：靶向EGFR和HGF的双特异性mAB-方抗体的益处
5. Bispecific antibody targeted stem cell therapy for myocardial repair. [D] . Gu, Yiping. 2008

机译：双特异性抗体靶向干细胞疗法用于心肌修复。
6. Development of tibulizumab a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease [O] . Robert J. Benschop, Chi-Kin Chow, Yu Tian, 2019

机译：开发tibulizumab一种靶向BAFF和IL-17A的四价双特异性抗体用于治疗自身免疫性疾病
7. Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease [O] . Robert J. Benschop, Chi-Kin Chow, Yu Tian, 2019

机译：钛合金的发展，靶向靶向BAFF和IL-17A的四价双特异性抗体，用于治疗自身免疫性疾病
8. Engineering Bispecific Antibodies That Target ERBB-2 on Breast Cancer Cells [R] . Krantz, D. M. 1999

机译：工程双特异性抗体靶向乳腺癌细胞ERBB-2

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号